Pharmaceutical drug costs & m-health
38 views | +0 today
Follow
 
Rescooped by Marcus Healey from Doctor
onto Pharmaceutical drug costs & m-health
Scoop.it!

Survey: 80% of smartphone users would like to use their devices to interact with HCPs

Survey: 80% of smartphone users would like to use their devices to interact with HCPs | Pharmaceutical drug costs & m-health | Scoop.it

A survey (n=2,239) of smartphone users across geographies found that:

 

* 71% of smartphone users are open to offers of relevant health care services from businesses

* 80% of patients would like the option to use their smartphones to interact with health care providers

* 56% of people worldwide trust health care organisations with personal data and indicated that while e-health records have yet to take off in many countries, innovations around mobile alerts and information services are helping build trust


Via Andrew Spong
Marcus Healey's insight:

The impending m-health revolution is in its infancy, but coming sooner than planned?

more...
No comment yet.
Your new post is loading...
Your new post is loading...
Rescooped by Marcus Healey from Biomarkers and Personalized Medicine
Scoop.it!

New Schizophrenia Diagnostic Method Found - Bioscience Technology - Bioscience Technology

New Schizophrenia Diagnostic Method Found - Bioscience Technology - Bioscience Technology | Pharmaceutical drug costs & m-health | Scoop.it
Bioscience Technology New Schizophrenia Diagnostic Method Found - Bioscience Technology Bioscience Technology Researchers have discovered a method for physical diagnosis of schizophrenia by collecting tissue from the nose Schizophrenia, a...

Via Brian Shields
Marcus Healey's insight:

No good diagnostics exist for the early detection of schizophrenia, a disease that affects approximately 1% of the world's population. Researchers in Israel are exploring early detection techniques by sampling by sampling neurons in frontal part of the brain and examining the microRNA. Ouch!

more...
Brian Shields's curator insight, April 30, 2013 11:06 PM

Very interesting development in psychiatry...scientists from Tel Aviv University and Johns Hopkins identify olfactory neurons that may possibly be used for early diagnosis of schizophrenia.  It is not clear yet whether this biomarker is apparent before symptoms appear.

Florence Piron's comment, May 3, 2013 8:32 AM
Don't you find it a strange and very limited method to work on a very complex disease with strong social and psychological components??
Brian Shields's comment, May 23, 2013 10:26 PM
Yes, a very strange development for a complex disease. However, scientists are doing a nice job now of monitoring the signals that our body produces to better diagnose and treat these difficult diseases. Perhaps scientists have realized that treating schizophrenia after it has already been diagnosed is a difficult path to follow. Perhaps early detection is the path toward a better treatment paradigm?
Scooped by Marcus Healey
Scoop.it!

Oncology Fellows, Clinicians Report Similar Burnout --Doctors Lounge

Oncology Fellows, Clinicians Report Similar Burnout --Doctors Lounge | Pharmaceutical drug costs & m-health | Scoop.it
Oncology Fellows, Clinicians Report Similar Burnout: Oncology fellows may underestimate future workload of act... http://t.co/u74Uu2n4Zh
Marcus Healey's insight:

Virtually all healthcare workers and the supporting staff in hospitals are suffering....long, long hours....working worried. Many losing jobs as hospitals close departments such as L&D (often loss leaders, though they bring in families) and hone their focus on profit centers.

more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Hepatitis drugs save money in long run

Hepatitis drugs save money in long run | Pharmaceutical drug costs & m-health | Scoop.it
New hepatitis C drugs can save lives. Critics say they're too costly, but John Castellani says in the long run they will save health care dollars.
Marcus Healey's insight:

I agree with L Gorman and J Castellani: costs will come down in the long run. Unfortunately, most people's lives....particularly if they are suffering with hepatitis C...are focused on the short run.

more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Frost & Sullivan: Companion Diagnostics Benefit from Fewer Regulatory Barriers ... - MarketWatch

Frost & Sullivan: Companion Diagnostics Benefit from Fewer Regulatory Barriers ... - MarketWatch | Pharmaceutical drug costs & m-health | Scoop.it
Frost & Sullivan: Companion Diagnostics Benefit from Fewer Regulatory Barriers ...
Marcus Healey's insight:

Regulatory barriers are likely to rise for CDx. Currently, CDx are seen in oncology, but new tests are rapidly being developed for CNS, cardiac and other disease states. Reimbursement is variable across different countries in EU and in US.

more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

PHARMACEUTICAL INFORMATION: FDA Approves Two Drugs, Companion Diagnostic Test for Advanced Skin Cancer

PHARMACEUTICAL INFORMATION: FDA Approves Two Drugs, Companion Diagnostic Test for Advanced Skin Cancer | Pharmaceutical drug costs & m-health | Scoop.it
PHARMACEUTICAL INFORMATION: FDA Approves Two Drugs, Companion Diagnostic Test ... http://t.co/8LxbcZblia
more...
No comment yet.
Rescooped by Marcus Healey from Doctor
Scoop.it!

Survey: 80% of smartphone users would like to use their devices to interact with HCPs

Survey: 80% of smartphone users would like to use their devices to interact with HCPs | Pharmaceutical drug costs & m-health | Scoop.it

A survey (n=2,239) of smartphone users across geographies found that:

 

* 71% of smartphone users are open to offers of relevant health care services from businesses

* 80% of patients would like the option to use their smartphones to interact with health care providers

* 56% of people worldwide trust health care organisations with personal data and indicated that while e-health records have yet to take off in many countries, innovations around mobile alerts and information services are helping build trust


Via Andrew Spong
Marcus Healey's insight:

The impending m-health revolution is in its infancy, but coming sooner than planned?

more...
No comment yet.
Rescooped by Marcus Healey from Social Media and Healthcare
Scoop.it!

Five healthcare innovations to get excited about

Five healthcare innovations to get excited about | Pharmaceutical drug costs & m-health | Scoop.it

With Canada’s aging population, the fact that about 40 percent of women could develop cancer in their lifetimes, and that heart disease and stroke are among the leading causes of death in women, it’s likely that many Canadian women will require medical treatment at some point in their lives.

Given this critical need, hospitals in Canada are quickly becoming the most innovative in the world. Many are being designed to provide patients with access to faster and better-quality care while others allow patients to take more control over their own health care needs. Here are 10 innovations you can get excited about:

1. Mobile health careSmartphones and tablets make it easy to monitor health care information on the go. Count calories, track physical activity, calculate body mass index (BMI) and ask medical questions.

Try it for yourself: Bant is an app developed in Canada that simplifies diabetes management for patients.

2. Social mediaUsed by patients to share health care information, new support sites let people connect with others undergoing similar experiences, to share advice and provide comfort and encouragement.

Try it for yourself:CancerConnection.ca allows anyone dealing, either directly or indirectly, with cancer to share their experiences and build supportive relationships.

DiabetesCareCommunity.ca is Canada’s first social network and online resource for families and friends of people with diabetes.

YoungAdultCancerCanada.ca is an online information and support resource that uses social media to connect young people diagnosed with cancer.

3. Bedside technologyHospital rooms are going high-tech with new interactive patient portals providing communication, education and entertainment—patients can contact nurses and order meals, learn more about their condition, as well as access TV shows and movies.

Toronto’s Humber River Hospital, opening in 2015, will be North America’s first fully digital hospital. Using the latest technologies to put patients and families at the centre of their care, the hospital will have online registration and electronic health records and bedside room-environment control.

4. Point-of-care diagnosticsLab tests are critical in diagnosis and monitoring of patients with acute and chronic diseases. These tests are largely done in central laboratories in hospitals or reference laboratories. Advances in point-of-care testing (PoCT) technologies allow for some of the routine tests (such as blood sugar and certain other critical tests) to be run outside of the laboratory quickly, often with just a few drops of the patient’s blood. These tests offer the convenience of fast and reliable results. PoCT programs allow for faster assessment and monitoring of patients, and improve patient care.

National Research Corporation Canada has developed a Point-of-Care app that allows health care leaders making hospital rounds to deliver real-time data and reports to other departments so patient issues are resolved quickly. This leads to a better experience for patients.

5. Virtual visitsRemote monitoring of patients allows for virtual visits to be conducted by teleconference or video conference – a specialist from across the country can examine a patient and give a diagnosis, saving the time and high cost of travel.

Try it yourself: Ontario Telemedicine Network is the world leader in telemedicine, using innovative technology to streamline health care processes, while also expanding the way knowledge is shared and how the medical community interacts with each other and with patients.


Via Plus91
more...
Greg Judd's curator insight, July 30, 2014 11:02 PM

The innovations Canadian health care observers are excited about share a focus on putting care where people are, rather than where clinicians gather, and introducing gear that enables doing medical testing  - stuff like blood tests for diagnosis & monitoring - faster and less invasively.

Scooped by Marcus Healey
Scoop.it!

POINT OF CARE TESTING

POINT OF CARE TESTING Near patient testing also termed as, "point of care testing" (POCT), is being increasingly relied upon by the health care community and...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

In Focus: Specialty Drugs

An inside look at how the high price of specialty drugs is affecting workers compensation costs.
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Effective Utilization Management Programs for Specialty Pharmacies

Specialty pharmacies can minimize "cost to treat" by identifying which specialty drugs have dose optimization opportunities, noted Michael Einodshofer, RPh, ...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Steve Marciniak, RPh, Addresses the Best Practices for Specialty Drug Benefit Management

Steve Marciniak, RPh, Pharmacy Director, Priority Health, states that formulary management, benefit design, distribution channels and patient care are curren...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

The Complex World of Lesion Data Collection

The Complex World of Lesion Data Collection | Pharmaceutical drug costs & m-health | Scoop.it
Getting effective treatments to patients more quickly is an industry goal and especially important within oncology studies.
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Millions and Millions of Possible Drug Combinations - Clinical Oncology News

Millions and Millions of Possible Drug Combinations - Clinical Oncology News | Pharmaceutical drug costs & m-health | Scoop.it
Millions and Millions of Possible Drug Combinations
Clinical Oncology News
...
Marcus Healey's insight:

The internet is revolutionizing medical care: m-health applications and  the ability to remotely examine patients and send data. In the clinical trial arena for oncology, M Markman raises an interesting point regarding the current clinical trial paradigm and our inability to adequately test drugs and combinations. A possible path was offered:N=1 trials and public accessibility of this data.

more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Mobile Apps Expanding Into POCT

The fastest-growing segment of the IVD market is point-of-care testing and the abundance of health apps for mobile devices will vastly change how healthcare is delivered.

Marcus Healey's insight:

We are moving past the FitBit stage at the speed of light. What to do with all that data? What is its impact on real world evidence collection?

more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

The Good, the Bad and the Ugly Truth about Specialty Drugs | Health Policy Blog | NCPA.org

The Good, the Bad and the Ugly Truth about Specialty Drugs | Health Policy Blog | NCPA.org | Pharmaceutical drug costs & m-health | Scoop.it
Recently, my colleague Linda Gorman wrote about Sovaldi, a new treatment for Hepatitis C that actually cures about 90 percent of patients taking it within three (The Good, the Bad and the Ugly Truth about Specialty Drugs
Marcus Healey's insight:

L Gorman's article (NCPA) makes a great parallel for Sovaldi: insulin in the early days when demand was higher than supply. Diabetes is still an expensive disease, but costs have come down as the supply of products has increased.

more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

The value of companion diagnostics Part 2

Industry thought leaders discuss the value of companion diagnostics in cancer pathology, and their impact on the personalized healthcare model, healthcare pr...
Marcus Healey's insight:

From a market access point of view, companion diagnostics go a long way towards calming payer anxiety.

more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Secret Service Shines Light On Skimming Devices - WFMY News 2

Secret Service Shines Light On Skimming Devices - WFMY News 2 | Pharmaceutical drug costs & m-health | Scoop.it
Secret Service Shines Light On Skimming Devices
WFMY News 2
They are constantly notified about the devices that he showed us, spread out on a table. They are called skimmers.
Marcus Healey's insight:

And you thought skimmers were what baristas at Starbucks used to remove excess foam from your latte! No wonder I don't sleep well.

more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

AT&T's emerging devices head: Expect 'fully independent ...

AT&T's emerging devices head: Expect 'fully independent ... | Pharmaceutical drug costs & m-health | Scoop.it
Wearable devices will reach a point later this year where they are “fully independent” — that is, not dependent on a smartphone — according to AT&T's head of emerging devices Glenn Lurie. But, despite some probing at our ...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

POCT: Expanding Avenues into Multiple Disease Diagnosis

POCT industry players are responding to new opportunities and growing end user needs through expansion of product lines for diverse disease diagnosis. For instance, an example that depicts the trend of exploring previously unexplored disease profiles by POCT players, the world’s first bedside genetic test for heart patients was recently developed by Spartan Bioscience. In less than an hour, the device analyzes the DNA obtained from saliva swab and determines the best drug option for the pa ...

more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

PhRMA, Advocates: Specialty Drug Costs Too High - WebMD

PhRMA, Advocates: Specialty Drug Costs Too High - WebMD | Pharmaceutical drug costs & m-health | Scoop.it
PhRMA, Advocates: Specialty Drug Costs Too High WebMD Here's the next salvo in the back and forth between insurers and the drug industry over drug prices: the Pharmaceutical Research and Manufacturers of America are pushing the Department of Health...
more...
No comment yet.
Rescooped by Marcus Healey from Melanoma BRAF Inhibitors Review
Scoop.it!

BRAF inhibitors in clinical oncology - F1000Prime Reports

BRAF inhibitors in clinical oncology - F1000Prime Reports | Pharmaceutical drug costs & m-health | Scoop.it
BRAF inhibitors in clinical oncology

 

Activating mutations of the BRAF oncogene are present in approximately 5-10% of all human malignancies and lead to constitutive activation of the mitogen activated protein kinase (MAPK) pathway. The introduction of BRAF inhibitors has greatly improved the short term prospects of some patients with these tumors, but the tumors tend to become resistant to therapy with time by activating alternative signaling pathways. Consequently, combination strategies with drugs that block not only the primary mutated BRAF kinase but also the alternative pathways implicated in development of resistance may represent a better strategy for improving survival in patients with tumors harboring BRAF mutations.


Via Krishan Maggon
more...
Krishan Maggon 's curator insight, July 9, 2014 11:33 AM
F1000Prime » F1000Prime Reports » Medicine »BRAF inhibitors in clinical oncology

 

Add to TwitterAdd to Mendeley Van Morris1 and Scott Kopetz2

 

1. Division of Cancer Medicine, The University of Texas – M.D. Anderson Cancer Center, Houston, TX
2. Division of Gastrointestinal Medical Oncology, The University of Texas – M.D. Anderson Cancer Center, Houston, TX

Corresponding author

 

F1000Prime Rep2013, 5:11 (doi: 10.12703/P5-11)Published: 02 Apr 2013 © 2013 Faculty of 1000 Ltd

The electronic version of this article is the complete one and can be found at:http://f1000.com/prime/reports/m/5/11

The PDF of this article can be found at: http://f1000.com/reports/m/5/11/pdf ;
Scooped by Marcus Healey
Scoop.it!

Supporting Consumer Access to Specialty Medications Through Value-Based Insurance Design

Access to specialty medications is a particularly pressing issue for many people who rely on these treatments for conditions that are often very serious, and...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Aimee Tharaldson, PharmD, Talks About Specialty Drug Approvals

In this video, Aimee Tharaldson, PharmD, Senior Clinical Consultant, Emerging Therapeutics Express Scripts, Inc, says that the increasing of specialty medica...
more...
No comment yet.